Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

Keywords

MedicineTemozolomideClinical trialMedical physicsOncologyInternal medicineIntensive care medicineChemotherapy

MeSH Terms

AdultAnimalsAntineoplastic AgentsAlkylatingClinical TrialsPhase I as TopicClinical TrialsPhase II as TopicDacarbazineFemaleHumansMaleMiddle AgedNeoplasmsExperimentalTemozolomideTumor CellsCultured

Affiliated Institutions

Related Publications

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer , Christina Lacchetti , Bryan J. Schneider +26 more

Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint i...

2018 Journal of Clinical Oncology 3484 citations

Overdiagnosis in Cancer

H. Gilbert Welch , William C. Black

This article summarizes the phenomenon of cancer overdiagnosis-the diagnosis of a "cancer" that would otherwise not go on to cause symptoms or death. We describe the two prerequ...

2010 JNCI Journal of the National Cancer I... 1543 citations

Colorectal cancer

Evelien Dekker , Pieter J. Tanis , Jasper L.A. Vleugels +2 more

2019 The Lancet 4583 citations

A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts

Elliott M. Antman

Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a...

1992 JAMA 1459 citations

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Charlotte Roach , Nancy Zhang , Ellie Corigliano +7 more

A companion diagnostic assay was codeveloped by Dako for pembrolizumab non–small-cell lung cancer clinical trials to detect PD-L1 expression by immunohistochemistry (IHC). This ...

2016 Applied immunohistochemistry & molecu... 346 citations

Publication Info

Year: 1997
Type: review
Volume: 23
Issue: 1
Pages: 35-61
Citations: 797
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

797

OpenAlex

Influential

655

CrossRef

Cite This

APA Style

                            
                                
                                    E.S. Newlands, 
                                
                                    M. F. G. STEVENS, 
                                
                                    Stephen R. Wedge
                                
                                et al.
                            
                            (1997). 
                            Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. 
                            Cancer Treatment Reviews
                            , 23
                            (1)
                            , 35-61.
                            https://doi.org/10.1016/s0305-7372(97)90019-0
                        

Identifiers

DOI: 10.1016/s0305-7372(97)90019-0
PMID: 9189180

Data Quality

Data completeness: 68%